2003
DOI: 10.1200/jco.2003.05.069
|View full text |Cite
|
Sign up to set email alerts
|

Early Detection of Response to Radiation Therapy in Patients With Brain Malignancies Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance Imaging

Abstract: The significant correlation between changes in diffusion parameters 1 week after initiating treatment and later tumor response or no response suggests the feasibility of using DWMRI for early, noninvasive prediction of tumor response. The ability to predict response may enable early termination of treatment in nonresponding patients, prevent additional toxicity, and allow for early changes in treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
137
0
1

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 260 publications
(148 citation statements)
references
References 19 publications
10
137
0
1
Order By: Relevance
“…On a patient-bypatient basis, fDM had a sensitivity and a specificity of 100%. This current study significantly extends earlier work accomplished in rodent brain tumors (13,20,21,(23)(24)(25)28) and the preliminary clinical observations in patients with brain and other cancer types (28)(29)(30)(31)(32). The advancement reported in this study was achieved by using coregistered MRI datasets along with thresholding allowing for quantification of change in treatment-induced tumor diffusion values.…”
Section: Discussionsupporting
confidence: 74%
See 1 more Smart Citation
“…On a patient-bypatient basis, fDM had a sensitivity and a specificity of 100%. This current study significantly extends earlier work accomplished in rodent brain tumors (13,20,21,(23)(24)(25)28) and the preliminary clinical observations in patients with brain and other cancer types (28)(29)(30)(31)(32). The advancement reported in this study was achieved by using coregistered MRI datasets along with thresholding allowing for quantification of change in treatment-induced tumor diffusion values.…”
Section: Discussionsupporting
confidence: 74%
“…However, clinical utility of this approach has been hampered because of tumor heterogeneity and suboptimal methods of digital image analysis (28)(29)(30)(31)(32). Furthermore, although these preliminary studies have shown correlations between ADC change and tumor response, a definitive study demonstrating the ability of diffusion MRI to predict response has not been reported.…”
mentioning
confidence: 99%
“…The World health organization classification subcategorizes the pineal parenchymal tumour into three classes: pineocytoma, pineoblastoma, and pineal parenchymal tumour of intermediate differentiation 2,8 . compared to pineocytoma, pineoblastoma is characterized by early onset (first two decades vs third or fourth decades), infiltration into surrounding structures, primitive neuroectodermal cell composition, presence of homer-Wright or Flexner-Wintersteiner rosettes, frequent brain metastasis or spinal seeding and worse prognosis (five-year survival rate: 58% vs 86%) [1][2][3]9 .…”
Section: Discussionmentioning
confidence: 99%
“…In the first step the dataset of ADc maps before and after treatment were co-registered to each other using the software statistical Parametric Mapping (sPM5) (Welcome Department of Imaging Neuroscience, london, UK) 7,8 . Then, for every pixel the percentual increase of ADc was estimated using the equation [(ADc post -ADc pre )/ADc pre x100%], where ADc pre describes the ADc before treatment and ADc post after treatment.…”
Section: Imaging Post-processing and Analysismentioning
confidence: 99%
“…These changes would be expected to be detectable prior to macroscopic changes in mass, size or morphology since removal of tumor macromolecular debris occurs relatively slowly. In fact, clinical studies have shown that dMRI can predict tumor response often several months prior to detectable radiographic changes [13][14][15][16][17][18]. Therefore, we decided to study the effectiveness of dMRI to predict response in patients with pancreatic cancer receiving neoadjuvant chemoradiation therapy.…”
Section: Introductionmentioning
confidence: 99%